Sabra Health Care REIT, Inc.: Form 10-K for the period ended Dec 31, 2022
Filed with the SEC on Feb 21, 2023 and accepted by EDGAR at Feb 21, 2023, 16:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | $186.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Income tax | 12 months2022-01-01 to 2022-12-31 | $1.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-01 to 2022-12-31 | −$77.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | −$0.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | −$0.34 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-01 to 2022-12-31 | 230,947,895 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | $315.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months2022-01-01 to 2022-12-31 | $277.2m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2022-12-31 | $49.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2022-12-31 | $5.75bn | us-gaap:Assets |
| Total liabilities | At period end2022-12-31 | $2.69bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-12-31 | $2.51bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2022-12-31 | $3.06bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001492298-23-000006. Last ingested by Listed: Nov 2, 2026, 16:50 ET. Listed shows no prices and gives no investment advice.